CMS' Medical Evidence Development & Coverage Advisory Committee (MEDCAC) will meet May 16 to discuss the agency's coverage with evidence development (CED) policy -- an approach increasingly relied upon by CMS and about which stakeholders are raising key questions, according to a new Avalere analysis. The analysis shows that 15 percent of national coverage determinations (NCDs) since 2006 resulted in coverage with evidence determination -- up from 10 percent in prior years -- even though some commenters question the policy’s...